Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
T2D, Obesity and Heart Failure: Breaking the Pathophysiologic Triangle Dr. Kamal Kant Kohli19 March 2026 10:15 AM ISTIndia's diabetes burden has risen markedly, with 101 million individuals living with diabetes. The clinical burden is compounded by heart failure...
Patients regain weight rapidly after stopping weight loss drugs-but still keep off quarter of weight lost, states study Dr. Kamal Kant Kohli5 March 2026 8:45 PM ISTA year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight-but beyond this, their...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
Novo Nordisk to Invest USD 506 Million to Expand Oral GLP-1 Drug Manufacturing in Ireland sheeba farhat3 March 2026 8:46 PM ISTNew Delhi: Novo Nordisk said on Monday it will invest 432 million euros (USD 506.43 million) to expand its manufacturing facility in Athlone,...
GLP-1 drugs like Ozempic could cut risk of major heart complications after heart attack, study finds Dr. Kamal Kant Kohli3 March 2026 8:30 PM ISTWeight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further...
NICE 2026 Updates Type 2 Diabetes Care: Cardiovascular Focus, Early SGLT-2 Use Takes Forefront Aditi Dhingra2 March 2026 12:30 PM ISTThe most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
US Wholesaler Files Class Action Against Novo Nordisk Over Diabetes Drug Victoza Monopoly Claims sheeba farhat27 Jan 2026 2:47 PM ISTSmith Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers.
Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia Dr. Kamal Kant Kohli19 Jan 2026 8:15 PM ISTA large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated...
Medical Bulletin 12/January/2026 Anshika Mishra12 Jan 2026 3:00 PM ISTHere are the top medical news for today:India on verge of lung cancer epidemic; Study warns India faces a looming lung cancer crisis—and it's hitting...
